What do you think, how many people still take their prescribed drugs after 12? Actually, the numbers are quite scary and vary significantly by the type of the disease. What is really scary, that even in disease conditions which are life threatening, often patients do not take their drugs.
So, for example: only 1 in 4 patients takes their asthma drug after 12 months, ony every second patients takes their diabetes medication after 12 months and just a little more than half of the patients take their HIV and MS drugs after one year.
These facts about drug compliance are another way to express the high unmet medical needs in our society. There is clear need for better therapies and medications. We need drugs with less side effects, drugs which are more effective and drugs which have long acting mechanisms in order to improve compliance of patients. Drug costs only make up for around 10% of total healthcare costs and especially chronic disease are important to control as they often lead to secondary malignancies if these diseases are not treated what increases overall costs to the society. Non-adherence costs are estimated to reach USD 290 bn as for example 10% of all hospitalizations go back to bad adherence to therapy.
Happy Birthday! Our Kieger Impact Healthcare Fund is turning 1! On this occasion, we are proud to share our Kieger AG Impact Healthcare Report, where we highlight the progress achieved during the past year and reflect on what have been unparalleled times.
“Sell in May and go away, but remember to come back in September” ... or perhaps October? Most stock markets reached new highs in early September, with economies have seemingly finally put the pandemic behind. At such a "cruising altitude," small turbulences can lead to serious corrections – and the month certainly offered plenty.
Will they/Won’t they? The Jackson Hole meeting at the end of August and the question around slowing the pace of bond purchases spooked the market throughout the whole month (next to the Delta-variant). In such times of uncertainties Healthcare (2.8%) did what it is supposed to do: it outperformed the market (2.5%). Year to date, Healthcare (17.2%) trades now almost on par with the global markets (17.9%)